Literature DB >> 32589698

Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.

Johanna Veldman1, Lydia Visser1, Magdalena Huberts-Kregel2, Natasja Muller1, Bouke Hepkema2, Anke van den Berg1, Arjan Diepstra1.   

Abstract

A unique feature of Hodgkin lymphoma (HL) is the presence of CD4+ T cells that surround, protect, and promote survival of tumor cells. The adhesion molecules involved in this so-called T-cell rosetting are important components of the immunological synapse (IS). However, it is unknown whether this synapse is fully assembled and leads to T-cell activation by enabling interaction between the T-cell receptor (TCR) and human leukocyte antigen class II (HLA-II). We established a novel rosetting model by coculturing HLA-II-matched peripheral blood mononuclear cells with HL cell lines and showed IS formation with activation of rosetting T cells. HLA-II downregulation by class II transactivator knockout did not affect the extent of rosetting, but almost completely abrogated T-cell activation. Intriguingly, the level of CD58 expression correlated with the extent of rosette formation, and CD58 knockout or CD2 blockade reduced both rosette formation and T-cell activation. The extension of our findings to primary HL tissue by immunohistochemistry and proximity ligation assays showed interaction of CD2 with CD58 and of TCR-associated CD4 with HLA-II. In conclusion, T-cell rosetting in HL is established by formation of the IS, and activation of rosetting T cells critically depends on the interaction of both TCR-HLA-II and CD2-CD58.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32589698      PMCID: PMC7685209          DOI: 10.1182/blood.2020005546

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Cutting edge: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site.

Authors:  Rossana Zaru; Thomas O Cameron; Lawrence J Stern; Sabina Müller; Salvatore Valitutti
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment.

Authors:  Fathima Zumla Cader; Ron C J Schackmann; Xihao Hu; Kirsty Wienand; Robert Redd; Bjoern Chapuy; Jing Ouyang; Nicole Paul; Evisa Gjini; Mikel Lipschitz; Philippe Armand; David Wu; Jonathan R Fromm; Donna Neuberg; X Shirley Liu; Scott J Rodig; Margaret A Shipp
Journal:  Blood       Date:  2018-06-07       Impact factor: 22.113

3.  A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts.

Authors:  M L Dustin; M W Olszowy; A D Holdorf; J Li; S Bromley; N Desai; P Widder; F Rosenberger; P A van der Merwe; P M Allen; A S Shaw
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

4.  The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing.

Authors:  Y Liu; F R Abdul Razak; M Terpstra; F C Chan; A Saber; M Nijland; G van Imhoff; L Visser; R Gascoyne; C Steidl; J Kluiver; A Diepstra; K Kok; A van den Berg
Journal:  Leukemia       Date:  2014-06-20       Impact factor: 11.528

5.  CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse.

Authors:  F R Abdul Razak; A Diepstra; L Visser; A van den Berg
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

6.  Rosetting and other reactions of the Reed-Sternberg cell.

Authors:  A E Stuart; A R Williams; J A Habeshaw
Journal:  J Pathol       Date:  1977-06       Impact factor: 7.996

7.  Amplification of TCRbeta gene rearrangements from micromanipulated single cells: T cells rosetting around Hodgkin and Reed-Sternberg cells in Hodgkin's disease are polyclonal.

Authors:  A Roers; M Montesinos-Rongen; M L Hansmann; K Rajewsky; R Küppers
Journal:  Eur J Immunol       Date:  1998-08       Impact factor: 5.532

8.  HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

Authors:  Arjan Diepstra; Gustaaf W van Imhoff; Henrike E Karim-Kos; Anke van den Berg; Gerard J te Meerman; Marijke Niens; Ilja M Nolte; Esther Bastiaannet; Michael Schaapveld; Edo Vellenga; Sibrand Poppema
Journal:  J Clin Oncol       Date:  2007-05-29       Impact factor: 44.544

9.  In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease.

Authors:  S Poppema; A K Bhan; E L Reinherz; M R Posner; S F Schlossman
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

10.  Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.

Authors:  Winnie S Liang; Jo-Anne Vergilio; Bodour Salhia; Helen J Huang; Yasuhiro Oki; Ignacio Garrido-Laguna; Haeseong Park; Jason R Westin; Funda Meric-Bernstam; David Fabrizio; Vincent A Miller; Philip J Stephens; Michelle A Fanale; Jeffrey S Ross; Filip Janku
Journal:  Oncologist       Date:  2018-08-14
View more
  8 in total

Review 1.  Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Authors:  Taishi Takahara; Akira Satou; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Diagnostics (Basel)       Date:  2022-06-20

Review 2.  Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma.

Authors:  Naike Casagrande; Cinzia Borghese; Donatella Aldinucci
Journal:  Cancers (Basel)       Date:  2022-05-14       Impact factor: 6.575

3.  HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients.

Authors:  Geok Wee Tan; Peijia Jiang; Ilja M Nolte; Kushi Kushekhar; Rianne N Veenstra; Bouke G Hepkema; Ruth F Jarrett; Anke van den Berg; Arjan Diepstra
Journal:  Cancers (Basel)       Date:  2021-11-20       Impact factor: 6.639

Review 4.  The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good.

Authors:  Victoria Menéndez; José L Solórzano; Sara Fernández; Carlos Montalbán; Juan F García
Journal:  Cancers (Basel)       Date:  2022-03-07       Impact factor: 6.639

5.  High percentages of peripheral blood T-cell activation in childhood Hodgkin's lymphoma are associated with inferior outcome.

Authors:  Fengqing Cai; Hui Gao; Zhongsheng Yu; Kun Zhu; Weizhong Gu; Xiaoping Guo; Xiaojun Xu; Hongqiang Shen; Qiang Shu
Journal:  Front Med (Lausanne)       Date:  2022-08-10

Review 6.  CD58 Immunobiology at a Glance.

Authors:  Yalu Zhang; Qiaofei Liu; Sen Yang; Quan Liao
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

7.  CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.

Authors:  Johanna Veldman; Jessica Rodrigues Plaça; Lauren Chong; Miente Martijn Terpstra; Mirjam Mastik; Léon C van Kempen; Klaas Kok; Tomohiro Aoki; Christian Steidl; Anke van den Berg; Lydia Visser; Arjan Diepstra
Journal:  Oncoimmunology       Date:  2022-01-27       Impact factor: 8.110

Review 8.  The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.

Authors:  Giuseppe Ingravallo; Roberto Tamma; Giuseppina Opinto; Tiziana Annese; Francesco Gaudio; Giorgina Specchia; Tommasina Perrone; Pellegrino Musto; Gerardo Cazzato; Emilio Bellitti; Saverio Capodiferro; Eugenio Maiorano; Domenico Ribatti
Journal:  Diagnostics (Basel)       Date:  2022-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.